Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B. 2000

L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
Department of Infectious Diseases, University Hospital, Ostrava, Czech Republic. ludek.roznovsky@fnspo.cz

Perinatal transmission of and infection with hepatitis B (HBV) in early childhood are observed in a small proportion of the offspring of hepatitis B surface antigen (HBsAg)-positive mothers who are vaccinated against HBV immediately after giving birth. The children may be infected by wild-type HBV or by variants with amino acid substitutions in the "a" determinant of HBsAg, particularly at position 145 and, rarely, at positions 120, 126, 129, 131, 141, and 144. Four hundred and forty-six newborn infants of HBsAg-positive mothers in the northeastern part of the Czech Republic received combined active and passive immunisation against HBV. Only one child became an HBsAg carrier. This followed a mild, acute HBV illness in the beginning of the second year of his life. HBV DNA encoding the "a" determinant and surrounding region of HBsAg was sequenced after amplification from the plasma of the child and his mother. The child was infected with variants of HBsAg with substitutions at residues 137 and 139. The virus of the mother had changes at residues 120 and 121. HBV from both child and mother had an unusual substitution at residue 118 and seemed to be of the ayw subdeterminant.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia

Related Publications

L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
December 2000, Hybridoma,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
November 1984, British medical journal (Clinical research ed.),
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
September 1985, British dental journal,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
January 1995, Intervirology,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
March 1977, Diabete & metabolisme,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
February 1985, Japanese journal of medical science & biology,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
January 1981, Journal of medical virology,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
January 2006, Viral immunology,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
January 1984, Journal of medical virology,
L Roznovsky, and T J Harrison, and Z L Fang, and R Ling, and I Lochman, and I Orsagova, and L Pliskova
January 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Copied contents to your clipboard!